Pharmaceuticals and Politics: Will Political Opinion Affect the Future of HPV Vaccines?Decision ResourcesDecember 19, 2005 SKU: DECR1204236 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
5/15/2012 | published by: GBI Research
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
Summary
GBI Research, the leading
|
more...
|
$3,500.00
|
|
Emergency Contraception in Latvia
5/8/2012 | published by: Euromonitor International
Emergency contraception witnessed sales growth in 2011. The government was not successful in improving the birth rate, which could have affected development of emergency contraception in 2011. The birth rate remained stable and total population
|
more...
|
$900.00
|
|
Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Melanoma and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized
|
more...
|
$5,175.00
|
|
Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to
|
more...
|
$5,175.00
|
|
Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Prostate Cancer and by the two mechanism/target/effect areas of Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to
|
more...
|
$5,175.00
|
|
2012 Global HIV/AIDS Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
4/20/2012 | published by: Venture Planning Group
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and
|
more...
|
$4,850.00
|
|
Triple Analysis: Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar
|
more...
|
$5,175.00
|
|
Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the mechanism/target/effect of Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria
|
more...
|
$5,175.00
|
|
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
4/30/2012 | published by: GBI Research
Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules Summary GBI Research, the leading business intelligence provider, has released its latest research
|
more...
|
$3,500.00
|
Related Markets
- Diseases & Conditions
- AIDS, HIV & STDs
- Pharmaceuticals
- Regulation & Policy
- Vaccines
- Therapeutic Area
- Women's Health
- Vaccines
- Cancer Vaccines
Cancer Vaccines Reports
- Triple Analysis: Prostate Cancer, Cancer Vaccines and Protein Kinase Inhibitors
- Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Protein Kinase Inhibitors
- Triple Analysis: Melanoma, Cancer Vaccines and Protein Kinase Inhibitors
- Triple Analysis: Lymphoma, Cancer Vaccines and Protein Kinase Inhibitors
- Triple Analysis: Lung Cancer, Cancer Vaccines and Protein Kinase Inhibitors
